View Author
patient blood sample tetramer marrow plasma cytometry study analysis hsa-mir expression response result panel disease bone marrow fl ow cytometry plasma cells transplantation t-cell myeloma cmv infection flow cytometry count cmv-speci population recovery infection table monocyte lymphocytes center donor level bone marrow aspirates group reactivation range cancer control osi -7836 recipient leukemia cmv reactivation allogeneic monitoring cell transplantation assay cytomegaloviru ebv dna leukocyte number myelodysplastic syndromes leukocyte populations mirna -7836 bone marrow samples subpopulation method cytometric diagnosis treatment transplant infusion allele event t cells myeloid therapy ebv dna load minute value aspirate syndrome assessment b cells sot patients pp 65 myelodysplastic article
10 Most Recent Publications
|
Variable EBV DNA load distributions and heterogeneous EBV mRNA expression patterns in the circulation of solid organ versus stem cell transplant recipients
(Article)
Greijer, A.E. Stevens, S.J. Middeldorp, J.M. Verkuijlen, S.A. Juwana, H. Fleig, S.C. Verschuuren, E.A. Hepkema, B.G. Cornelissen, J.J. Brooimans, R.A. Verdonck, L.F. |
2012-12-01
|
|
Transition of highly specific microRNA expression patterns in association with discrete maturation stages of human granulopoiesis
(Article)
Sun, S.M. Dijkstra, M.K. Bijkerk, A. Brooimans, R.A. Valk, P.J.M. Erkeland, S.J. Löwenberg, B. Jongen-Lavrencic, M. |
2011-11-01
|
|
Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS
(Article)
Westers, T.M. Velden, V.H.J. van der Jong, A.P.H. de Kuiper-Kramer, P.(.).A. Leenders, C.M. Lommerse, I. Marvelde, J.G. te Molen-Sinke, J.K. van der Moshaver, B. Mulder, A.B. Preijers, F.W. Schindhelm, R.K. Alhan, C. Sluijs, A.J. van der Wering, E.R. van Westra, A.H. Loosdrecht, A.A. van de Bekkema, R. Bijkerk, A. Brooimans, R.A. Cali, C. Dräger, A.M. Haas, V. de Homburg, C.H. |
2011-10-06
|
|
Immune monitoring with iTAg MHCTetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: A prospective multicenter study
(Article)
Gratama, J-W. Boeckh, M. Boyce, C.S. Sullivan, L.A. Southwick, P.C. Nakamura, R. Cornelissen, J.J. Brooimans, R.A. Zaia, J.A. Forman, S.J. Gaal, K. Bray, K.R. Gasior, G.H. |
2010-09-09
|
|
Flow cytometric differential of leukocyte populations in normal bone marrow: Influence of peripheral blood contamination
(Article)
Brooimans, R.A. Kraan, J. Putten, W. van Cornelissen, J.J. Löwenberg, B. Gratama, J-W. |
2009-01-01
|
|
Analytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes
(Article)
Brooimans, R.A. Boyce, C.S. Popma, J. Broyles, D.A. Gratama, J-W. Southwick, P.C. Keeney, M. |
2008-11-01
|
|
Monitoring cytomegalovirus IE-1 and PP65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations
(Article)
Gratama, J-W. Brooimans, R.A. Holt, B. van der Sintnicolaas, K. Doornum, G.J.J. van Niesters, H.G.M. Löwenberg, B. Cornelissen, J.J. |
2008-07-01
|
|
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
(Article)
Rawstron, A.C. Orfao, A. Kovarova, L. Lioznov, M. Mateo, G. Morilla, R. Mylin, A.K. Omedé, P. Pellat-Deceunynck, C. Andres, M.P. Petrucci, M. Ruggeri, M. Beksac, M. Rymkiewicz, G. Schmitz, A. Schreder, M. Seynaeve, C.M. Spacek, M. Tute, R.M. de Valckenborgh, E. van Weston-Bell, N. Owen, R.G. San Miguel, J-F. Bezdickova, L. Sonneveld, P. Johnsen, H.E. Brooimans, R.A. Bumbea, H. Dalva, K. Fuhler, G.M. Gratama, J-W. Hose, D. |
2008-03-01
|
|
Leptomeningeal disease in chronic lymphocytic leukemia
(Article)
Lange, C.P.E. Brouwer, R.E. Brooimans, R.A. Vecht, C.J. |
2007-12-01
|
|
A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies
(Article)
Lee, C.P. Jonge, M.J.A. de Kaye, S.B. Judson, I.R. Verweij, J. O'Donnell, A.E. Schothorst, K.L. Hanwell, J. Chick, J.B. Brooimans, R.A. Adams, L.A. Drolet, D.W. Bono, J.S. de |
2006-05-01
|